BioMarin Pharmaceutical
BMRN
$81.04
Share price
-11.14%
Change (1 day)
-15.72%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) Fails to deliver data
Key failure to deliver metrics for BioMarin Pharmaceutical:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.04 M
- Last 3 months FTD volume: $2.19 M
- Last year FTD volume: $7.77 M
Failures to deliver for BioMarin Pharmaceutical (BMRN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for BioMarin Pharmaceutical (BMRN) - since 2013
Volume in USD (price x number of shares), data since 2013BioMarin Pharmaceutical (BMRN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $2.19 M | -91.55% |
| 2023 | $26 M | -3.87% |
| 2022 | $27.05 M | -24.36% |
| 2021 | $35.76 M | -61.48% |
| 2020 | $92.85 M | 217.25% |
| 2019 | $29.26 M | -60.68% |
| 2018 | $74.43 M | 66.59% |
| 2017 | $44.68 M | -18.44% |
| 2016 | $54.78 M | -33.54% |
| 2015 | $82.43 M | 51.23% |
| 2014 | $54.5 M | 57.97% |
| 2013 | $34.5 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $26.25 M | $54.4 M | 🇫🇷 France |
 Ultragenyx RARE | $3.42 M | $16.85 M | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.14 M | $1.62 M | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $3.36 M | $8.49 M | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $1.7 M | $4.65 M | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.42 M | $4.04 M | 🇺🇸 USA |